You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -50.5% | -66.7% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -11.3 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 5.9 | 4.8 |
| Price / Book value | 8.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 19.2% | 7.6% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -99.1% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | 7.16 | -1.84 | $-15.18 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2015-12-31 | 9.29 | -1.45 | $-1.86 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | 12.27 | -3.35 | $-0.11 | -15.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 13.98 | -9.92 | $-0.20 | -16.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 16.67 | -8.87 | $-0.17 | -14.2 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 16.07 | -10.71 | -0.19p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 19.14 | -8.98 | -0.16p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Sunday share tips: IQE, MaxCyte Sharecast News | 26 May |
|---|---|
| MaxCyte begins dosing second cohort in MCY-M11 clinical trial Sharecast News | 08 May |
| MaxCyte launches new generation of cellular engineering instruments Sharecast News | 08 Apr |
| Annual Report | 19-Jun-19 07:04 |
|---|---|
| Appointment of Joint Corporate Broker | 12-Jun-19 07:05 |
| Second Price Monitoring Extn | 08-May-19 16:42 |
| Price Monitoring Extension | 08-May-19 16:37 |
| Phase I Clinical Trial of MCY-M11 Progressed | 08-May-19 07:04 |